Navigation Links
Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease

And Japanese Study Suggests the Drug Improves Memory

SARASOTA, Fla., March 22, 2007 /PRNewswire-FirstCall/ -- The Roskamp Institute announced today that it has received positive preliminary results in its major clinical study that is testing a promising new drug application for the treatment of Alzheimer's disease. The clinical study, which was first announced in September, is the first human clinical study conducted by a Florida-based research institute as a result of its own original research. Today's announcement also highlighted achievements with the same drug in studies in Japan.

The drug, Nilvadipine, has not shown any major side effects in Alzheimer's disease patients during the initial six months of the study that is being conducted in partnership with the Trinity College Institute of Neuroscience in Dublin, Ireland. "This is a good indication that this drug will be safe in patients with Alzheimer's disease," said Dr. Michael Mullan, Director of the Roskamp Institute. "A staggering number of drugs fail once they go through their clinical studies due to safety issues. After treating more than a dozen Alzheimer patients with Nilvadipine, we can continue our studies because we have seen no serious side effects related to the drug."

This pilot study was the first step in trying to develop a potential treatment for Alzheimer's disease, and if it continues to be a success, could change the direction of other studies of dementia. In pre-clinical studies on mice, Nilvadipine was found to decrease the levels in the brain of a protein called beta amyloid. It is the presence of beta amyloid in the brain that is believed to cause the onset of Alzheimer's. The drug was also found to increase the flow of blood to the brain, which is believed to be beneficial in the treatment of the disease. The purpose of the study has been to determine whether the drug would have the same effect on humans suffering fro
'"/>




Page: 1 2

Related medicine technology :

1. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting
6. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:1/23/2015)... , Jan. 23, 2015  Today the U.S. Food ... Bexsero® for the prevention of serogroup B meningococcal ... and Pfizer,s vaccine Trumenba®, which received FDA approval in ... this devastating disease. "I have heard ...
(Date:1/23/2015)... Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) has announced the ... Foley Catheters, Intermittent Catheters and Male External or Condom ... and Forecast 2014 - 2020" report to their ... market for urinary catheters is experiencing a healthy growth ...
(Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3
... Technologies for Surgery , , TEXARKANA, Texas, June ... technology has three Texarkana neurosurgeons leading their industry by ... technique is improving the desired results of surgical interventions ... spine industry are predicting the latest developments in this ...
... Clofarabine, Thiarabine Achieves High Cure Rate in a Colorectal Cancer Model ... PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), ... data will shortly be published demonstrating that thiarabine combined with ... by either agent alone. In one colorectal cancer model, 66% of ...
Cached Medicine Technology:Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries 2Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries 3Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 2Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 3Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 4
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the ... reducing the costs of an auto insurance policy . ... get lower prices for their vehicle insurance policies. The safety a ... policy costs. Because of this, drivers should always carry a ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... have found that shock wave lithotripsy, which is given for ... also hypertension in later part of life. //Risk for diabetes ... of the shock waves administered; hypertension was related to treatment ... uses shock waves to break up an impassable kidney stone ...
... Lanka has increased in multifold with people consuming the poisonous seeds ... trivial reasons. ,This is an ornamental plant often used ... trumpet-like flowers and a fruit the size of a conker. Inside ... enough to kill you, the online edition of BBC News reported. ...
... Gujarat Health Minister Ashok Bhatt has confirmed the absence of ... of bird-flu// also yielded negative results. ,Kadar Murghiwala, ... under his care died. Suspecting a possible bird-flu infection following ... and kept in an isolation ward. The symptoms of bird-flu ...
... million Australians have diabetes. New South Wales (NSW) has recorded ... over the past 10 years. Experts have asked the health ... diabetes. Sooner if it continues it is expected that about ... reason for this increase is that of the diet and ...
... the drug system. Health Minister George Smitherman said that ... program//. He also said that he would introduce more ... sustainable. They will also speed up the slow drug ... taxpayers have not received fair value for their dollar, ...
... the state, Madhya Pradesh legislators seems to be totally unconcerned ... group//. ,The state, one of the largest in the ... childbirths while the maternal mortality rate stands at 498 per ... second highest rate of infant and maternal mortality in the ...
Cached Medicine News:Health News:Shock Wave Therapy Increase The Risk Of Diabetes 2Health News:Shock Wave Therapy Increase The Risk Of Diabetes 3Health News:Its High Time the Australian Government Takes Steps against Diabetes 2
... Lens enhances iridectomy procedures by providing ... conventional iridectomy lens designs) with exceptional ... this lens has been increased from ... The MagPlus comes standard with LaserWindow ...
... The Fundus 20mm is ... Fundus Lens. The Fundus 20mm ... an increased 20mm contact element. ... that the contact element sits ...
... re-designed Super Macula® 2.2 offers extremely high ... fovea, while achieving an exceptionally wide 78° ... excellent choice for critical evaluation of the ... for detailed views of the macula and ...
... This specially adapted QuadrAspheric design with 10mm ... and management of retinopathy of prematurety (ROP) ... developed to aid the practitioner in the ... as well as those individuals with narrow ...
Medicine Products: